These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 19929814)
1. The critical role of the endocannabinoid system in emotional homeostasis: avoiding excess and deficiencies. Marco EM; Viveros MP Mini Rev Med Chem; 2009 Oct; 9(12):1407-15. PubMed ID: 19929814 [TBL] [Abstract][Full Text] [Related]
2. Endocannabinoid binding to the cannabinoid receptors: what is known and what remains unknown. Reggio PH Curr Med Chem; 2010; 17(14):1468-86. PubMed ID: 20166921 [TBL] [Abstract][Full Text] [Related]
3. Development of endocannabinoid-based chemical probes for the study of cannabinoid receptors. Martín-Couce L; Martín-Fontecha M; Capolicchio S; López-Rodríguez ML; Ortega-Gutiérrez S J Med Chem; 2011 Jul; 54(14):5265-9. PubMed ID: 21675776 [TBL] [Abstract][Full Text] [Related]
4. The endocannabinoid system: physiology and pharmacology. Rodríguez de Fonseca F; Del Arco I; Bermudez-Silva FJ; Bilbao A; Cippitelli A; Navarro M Alcohol Alcohol; 2005; 40(1):2-14. PubMed ID: 15550444 [TBL] [Abstract][Full Text] [Related]
5. Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis. Cabranes A; Venderova K; de Lago E; Fezza F; Sánchez A; Mestre L; Valenti M; García-Merino A; Ramos JA; Di Marzo V; Fernández-Ruiz J Neurobiol Dis; 2005 Nov; 20(2):207-17. PubMed ID: 16242629 [TBL] [Abstract][Full Text] [Related]
6. Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors. Golech SA; McCarron RM; Chen Y; Bembry J; Lenz F; Mechoulam R; Shohami E; Spatz M Brain Res Mol Brain Res; 2004 Dec; 132(1):87-92. PubMed ID: 15548432 [TBL] [Abstract][Full Text] [Related]
7. The role of the pancreatic endocannabinoid system in glucose metabolism. Bermúdez-Silva FJ; Suárez Pérez J; Nadal A; Rodríguez de Fonseca F Best Pract Res Clin Endocrinol Metab; 2009 Feb; 23(1):87-102. PubMed ID: 19285263 [TBL] [Abstract][Full Text] [Related]
8. Innovative Therapeutic Potential of Cannabinoid Receptors as Targets in Alzheimer's Disease and Less Well-Known Diseases. Páez JA; Campillo NE Curr Med Chem; 2019; 26(18):3300-3340. PubMed ID: 29484980 [TBL] [Abstract][Full Text] [Related]
9. An introduction to the endocannabinoid system: from the early to the latest concepts. De Petrocellis L; Di Marzo V Best Pract Res Clin Endocrinol Metab; 2009 Feb; 23(1):1-15. PubMed ID: 19285257 [TBL] [Abstract][Full Text] [Related]
10. Cannabinoids and the gut: new developments and emerging concepts. Izzo AA; Sharkey KA Pharmacol Ther; 2010 Apr; 126(1):21-38. PubMed ID: 20117132 [TBL] [Abstract][Full Text] [Related]
11. Involvement of the endocannabinoid system in periodontal healing. Kozono S; Matsuyama T; Biwasa KK; Kawahara K; Nakajima Y; Yoshimoto T; Yonamine Y; Kadomatsu H; Tancharoen S; Hashiguchi T; Noguchi K; Maruyama I Biochem Biophys Res Commun; 2010 Apr; 394(4):928-33. PubMed ID: 20233580 [TBL] [Abstract][Full Text] [Related]
12. Microinjection of 2-arachidonoyl glycerol into the rat ventral hippocampus differentially modulates contextually induced fear, depending on a persistent pain state. Rea K; Ford GK; Olango WM; Harhen B; Roche M; Finn DP Eur J Neurosci; 2014 Feb; 39(3):435-43. PubMed ID: 24494683 [TBL] [Abstract][Full Text] [Related]
13. The endocannabinoid-CB receptor system: Importance for development and in pediatric disease. Fride E Neuro Endocrinol Lett; 2004; 25(1-2):24-30. PubMed ID: 15159678 [TBL] [Abstract][Full Text] [Related]
14. The endocannabinoid system in inflammatory bowel diseases: from pathophysiology to therapeutic opportunity. Alhouayek M; Muccioli GG Trends Mol Med; 2012 Oct; 18(10):615-25. PubMed ID: 22917662 [TBL] [Abstract][Full Text] [Related]
15. Endocannabinoid regulation of matrix metalloproteinases: implications in ischemic stroke. Mukhopadhyay S; Tulis DA Cardiovasc Hematol Agents Med Chem; 2007 Oct; 5(4):311-8. PubMed ID: 17979695 [TBL] [Abstract][Full Text] [Related]
16. Changes in the endocannabinoid system may give insight into new and effective treatments for cancer. Alpini G; Demorrow S Vitam Horm; 2009; 81():469-85. PubMed ID: 19647123 [TBL] [Abstract][Full Text] [Related]
18. Endocannabinoids activate transient receptor potential vanilloid 1 receptors to reduce hyperdopaminergia-related hyperactivity: therapeutic implications. Tzavara ET; Li DL; Moutsimilli L; Bisogno T; Di Marzo V; Phebus LA; Nomikos GG; Giros B Biol Psychiatry; 2006 Mar; 59(6):508-15. PubMed ID: 16199010 [TBL] [Abstract][Full Text] [Related]
19. Characterization of the endocannabinoid system, CB(1) receptor signalling and desensitization in human myometrium. Brighton PJ; Marczylo TH; Rana S; Konje JC; Willets JM Br J Pharmacol; 2011 Nov; 164(5):1479-94. PubMed ID: 21486283 [TBL] [Abstract][Full Text] [Related]
20. The endogenous cannabinoid system and the treatment of marijuana dependence. Piomelli D Neuropharmacology; 2004; 47 Suppl 1():359-67. PubMed ID: 15464150 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]